HealthMedical Breakthrough
Experimental Pill Nearly Doubles Pancreatic Cancer Survival
A new experimental pill nearly doubles survival for advanced pancreatic cancer patients, targeting the long-undruggable KRAS mutation.
—5 min read
Tag
1 article
A new experimental pill nearly doubles survival for advanced pancreatic cancer patients, targeting the long-undruggable KRAS mutation.